Synergistic effect of the rapamycin-cyclosporine combination: median effect analysis of in vitro immune performances by human T lymphocytes in PHA, CD3, and MLR proliferative and cytotoxicity assays.
Kahan
B D
BD
Department of Surgery, University of Texas Medical School, Houston.
Gibbons
S
S
Tejpal
N
N
Chou
T C
TC
Stepkowski
S
S
D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology; D017252:CD3 Complex; D002478:Cells, Cultured; D003524:Cyclosporins / Q000008:administration & dosage*; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D004357:Drug Synergism; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D066298:In Vitro Techniques; D008213:Lymphocyte Activation / Q000187:drug effects*; D007959:Lymphocyte Culture Test, Mixed; D010835:Phytohemagglutinins / Q000494:pharmacology; D011090:Polyenes / Q000008:administration & dosage; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D020123:Sirolimus; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology
D000945:Antigens, Differentiation, T-Lymphocyte; D017252:CD3 Complex; D003524:Cyclosporins; D010835:Phytohemagglutinins; D011090:Polyenes; D011948:Receptors, Antigen, T-Cell; D020123:Sirolimus